Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mutations in SARS-CoV-2 structural proteins: a global analysis
Mohammad Abavisani, Karim Rahimian, Bahar Mahdavi, et al.
Virology Journal (2022) Vol. 19, Iss. 1
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

mRNA Vaccines against SARS-CoV-2: Advantages and Caveats
Miriam Echaide, Luisa Chocarro, Ana Bocanegra, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 6, pp. 5944-5944
Open Access | Times Cited: 51
Wastewater-based surveillance as a tool for public health action: SARS-CoV-2 and beyond
Michael D. Parkins, Bonita E. Lee, Nicole Acosta, et al.
Clinical Microbiology Reviews (2023) Vol. 37, Iss. 1
Closed Access | Times Cited: 46
Intranasal COVID-19 vaccine induces respiratory memory T cells and protects K18-hACE mice against SARS-CoV-2 infection
Béré Diallo, Caitlín Ní Chasaide, Ting Y. Wong, et al.
npj Vaccines (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 32
Molecular Evolution of SARS-CoV-2 during the COVID-19 Pandemic
Luis Daniel González-Vázquez, Miguel Arenas
Genes (2023) Vol. 14, Iss. 2, pp. 407-407
Open Access | Times Cited: 27
The potential epidemiologic, clinical, and economic value of a universal coronavirus vaccine: a modelling study
Sarah M. Bartsch, Kelly J. O’Shea, Danielle C. John, et al.
EClinicalMedicine (2024) Vol. 68, pp. 102369-102369
Open Access | Times Cited: 11
Impact of mutations on the stability of SARS-CoV-2 nucleocapsid protein structure
Nelli Muradyan, Vahram Arakelov, Arsen Sargsyan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Antigen‐specific and cross‐reactive T cells in protection and disease
Ning Jiang, Michael Malone, Shahab Chizari
Immunological Reviews (2023) Vol. 316, Iss. 1, pp. 120-135
Closed Access | Times Cited: 16
Severe acute respiratory syndrome coronavirus 2 infection leads to Tau pathological signature in neurons
Cristina Di Primio, Paola Quaranta, Marianna Mignanelli, et al.
PNAS Nexus (2023) Vol. 2, Iss. 9
Open Access | Times Cited: 15
Perspectives on SARS-CoV-2 Cases in Zoological Institutions
Remco A. Nederlof, Melissa A. de la Garza, Jaco Bakker
Veterinary Sciences (2024) Vol. 11, Iss. 2, pp. 78-78
Open Access | Times Cited: 5
Two Years of SARS-CoV-2 Omicron Genomic Evolution in Brazil (2022–2024): Subvariant Tracking and Assessment of Regional Sequencing Efforts
Ueric José Borges de Souza, Fernando Rosado Spilki, Amílcar Tanuri, et al.
Viruses (2025) Vol. 17, Iss. 1, pp. 64-64
Open Access
Mathematical analysis of the COVID-19 pandemic dynamics in the emergence of resistant strains of SARS-CoV-2 in a vaccinated and non-vaccinated population: a real-world scenario in most countries
Ugo Avila-Ponce de León, Ángel Pérez, Eric Ávila-Vales
Elsevier eBooks (2025), pp. 63-80
Closed Access
Advances in bioinformatics and multi-omics integration: transforming viral infectious disease research in veterinary medicine
Alyaa Elrashedy, Walid Mousa, Mohamed Nayel, et al.
Virology Journal (2025) Vol. 22, Iss. 1
Open Access
Validation and implementation of TaqMAMA RT-PCR for SARS-CoV-2 variant surveillance: experience from a high-volume setting
José Nicolas Aguirre-Pineda, Mario Mújica-Sánchez, Hansel Hugo Chávez-Morales, et al.
BMC Infectious Diseases (2025) Vol. 25, Iss. 1
Open Access
Intersecting SARS-CoV-2 spike mutations and global vaccine efficacy against COVID-19
Samaneh Tokhanbigli, Samira Salami Ghaleh, Karim Rahimian, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Host Response Protein Biomarkers Indicative of Persistent Acute Kidney Injury in Critically Ill COVID-19 Patients
Thei S. Steenvoorden, Koen C. de Kruijf, Brent Appelman, et al.
Critical Care Explorations (2025) Vol. 7, Iss. 3, pp. e1222-e1222
Open Access
Genetic Variations of Three Kazakhstan Strains of the SARS-CoV-2 Virus
Bekbolat Usserbayev, Kulyaisan Sultankulova, Yerbol Burashev, et al.
Viruses (2025) Vol. 17, Iss. 3, pp. 415-415
Open Access
Ghosts of the past: Elemental composition, biosynthesis reactions and thermodynamic properties of Zeta P.2, Eta B.1.525, Theta P.3, Kappa B.1.617.1, Iota B.1.526, Lambda C.37 and Mu B.1.621 variants of SARS-CoV-2
Marko Popovic, Marijana R. Pantović Pavlović, Miroslav M. Pavlović
Microbial Risk Analysis (2023) Vol. 24, pp. 100263-100263
Open Access | Times Cited: 13
The End or a New Era of Development of SARS-CoV-2 Virus: Genetic Variants Responsible for Severe COVID-19 and Clinical Efficacy of the Most Commonly Used Vaccines in Clinical Practice
Dimitrina Miteva, Meglena Kitanova, Hristiana Batselova, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1181-1181
Open Access | Times Cited: 13
Upcoming epidemic storm: Empirical formulas, biosynthesis reactions, thermodynamic properties and driving forces of multiplication of the omicron XBB.1.9.1, XBF and XBB.1.16 (Arcturus) variants of SARS-CoV-2
Marko Popovic, Marija Mihailović, Stefan Panić
Microbial Risk Analysis (2023) Vol. 25, pp. 100273-100273
Closed Access | Times Cited: 13
Genomic surveillance of SARS‐CoV‐2 strains circulating in Iran during six waves of the pandemic
Kaveh Sadeghi, Sevrin Zadheidar, Arghavan Zebardast, et al.
Influenza and Other Respiratory Viruses (2023) Vol. 17, Iss. 4
Open Access | Times Cited: 12
Molecular Epidemiology of SARS-CoV-2 during Five COVID-19 Waves and the Significance of Low-Frequency Lineages
Kathleen Subramoney, Nkhensani Mtileni, Jennifer Giandhari, et al.
Viruses (2023) Vol. 15, Iss. 5, pp. 1194-1194
Open Access | Times Cited: 11
SARS‐CoV‐2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment
Akram Sadat Ahmadi, Sevrin Zadheidar, Kaveh Sadeghi, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 6
Closed Access | Times Cited: 11
Anti-SARS-CoV-2 activity of cyanopeptolins produced by Nostoc edaphicum CCNP1411
Robert Konkel, Aleksandra Milewska, Thuc Nguyen Dan, et al.
Antiviral Research (2023) Vol. 219, pp. 105731-105731
Open Access | Times Cited: 10
SARS-CoV-2 outbreak: role of viral proteins and genomic diversity in virus infection and COVID-19 progression
Hosni A. M. Hussein, Ali A. Thabet, Ahmed A. Wardany, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 3
Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease
Nikita Navolokin, Viktoria Adushkina, Daria Zlatogorskaya, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 788-788
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top